End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.37 USD | -1.69% | -7.15% | +16.46% |
04-30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.46% | 3.74B | |
+26.51% | 44.96B | |
-0.72% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.35% | 26.08B | |
-21.66% | 19.03B | |
+6.29% | 12.75B | |
+27.64% | 12.06B | |
-3.51% | 11.75B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Barclays Initiates Alvotech With Equalweight Rating, Price Target is $10